Serelaxin was found to increase kidney perfusion and oxygenation, reduce renal vascular resistance, reverse endothelial dysfunction, and increase the activation of the AKT/eNOS/NO signaling pathway in the kidneys [31]. The gene discussed is NOS3; the disease is endothelial dysfunction.